Načítá se...

The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5

b-AP15 and its derivatives block proteasome deubiquitinase (DUB) activity and have been developed and tested in the clinic as potential cancer therapeutic agents. b-AP15 induces apoptosis in cancer cells, but the underlying mechanisms are largely undefined. The current study focuses on studying the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Oh, You-Take, Deng, Liang, Deng, Jiusheng, Sun, Shi-Yong
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5556018/
https://ncbi.nlm.nih.gov/pubmed/28808321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-08424-w
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!